Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-02-14 10:10 am Sale | 13G | TELA BIO INC TELA | RTW INVESTMENTS LP | 390,364 2% | -1,009,322 (-72.11%) | View |
2023-02-14 10:10 am Sale | 13G | RELMADA THERAPEUTICS INC P RLMD | RTW INVESTMENTS LP | 2,067,824 6.9% | -118,500 (-5.42%) | View |
2023-02-14 10:09 am Purchase | 13G | MIRATI THERAPEUTICS INC MRTX | RTW INVESTMENTS LP | 3,643,114 6.3% | 3,643,114 (New Position) | View |
2023-02-14 10:09 am Purchase | 13G | TARSUS PHARMACEUTICALS INC TARS | RTW INVESTMENTS LP | 2,548,125 9.6% | 534,524 (+26.55%) | View |
2023-02-14 10:08 am Sale | 13G | CELLDEX THERAPEUTICS INC C CLDX | RTW INVESTMENTS LP | 3,084,215 6.5% | -837,364 (-21.35%) | View |
2023-02-14 10:08 am Purchase | 13G | STOKE THERAPEUTICS INC STOK | RTW INVESTMENTS LP | 3,870,981 9.8% | 226,733 (+6.22%) | View |
2023-02-14 10:08 am Purchase | 13G | C4 THERAPEUTICS INC CCCC | RTW INVESTMENTS LP | 2,819,472 5.8% | 324,507 (+13.01%) | View |
2023-02-14 10:08 am Sale | 13G | ITEOS THERAPEUTICS INC. ITOS | RTW INVESTMENTS LP | 0 0% | -2,353,015 (Position Closed) | View |
2023-02-14 10:07 am Purchase | 13G | PMV PHARMACEUTICALS INC PMVP | RTW INVESTMENTS LP | 4,356,920 9.5% | 1,375,960 (+46.16%) | View |
2023-02-14 10:07 am Purchase | 13G | AXSOME THERAPEUTICS INC AXSM | RTW INVESTMENTS LP | 2,980,482 6.9% | 2,980,482 (New Position) | View |
2023-02-14 10:07 am Purchase | 13G | JOUNCE THERAPEUTICS INC. JNCE | RTW INVESTMENTS LP | 5,106,341 9.9% | 2,243,143 (+78.34%) | View |
2023-02-14 10:06 am Purchase | 13G | IMMUNIC INC IMUX | RTW INVESTMENTS LP | 3,861,290 8.7% | 2,145,820 (+125.09%) | View |
2023-02-14 10:06 am Sale | 13G | LA JOLLA PHARMACEUTICAL COMP LJPC | RTW INVESTMENTS LP | 0 0% | -2,590,932 (Position Closed) | View |
2023-02-14 10:06 am Sale | 13G | IVERIC BIO INC ISEE | RTW INVESTMENTS LP | 821,288 0.6% | -5,901,336 (-87.78%) | View |
2023-02-14 10:06 am Purchase | 13G | PROMETHEUS BIOSCIENCES INC RXDX | RTW INVESTMENTS LP | 3,354,303 7.2% | 90,272 (+2.77%) | View |
2023-02-14 10:05 am Purchase | 13G | OYSTER PT PHARMA INC OYST | RTW INVESTMENTS LP | 2,304,977 8.6% | 246,473 (+11.97%) | View |
2023-02-14 10:05 am Purchase | 13G | IMMUNOCORE HLDGS PLC ADS IMCR | RTW INVESTMENTS LP | 5,559,322 12.3% | 5,559,322 (New Position) | View |
2023-02-14 10:04 am Purchase | 13G | FULCRUM THERAPEUTICS INC FULC | RTW INVESTMENTS LP | 4,993,279 9.6% | 1,126,407 (+29.13%) | View |
2023-02-14 10:04 am Purchase | 13G | PROTAGONIST THERAPEUTICS INC C PTGX | RTW INVESTMENTS LP | 3,591,986 7.3% | 992,164 (+38.16%) | View |
2023-02-14 10:04 am Sale | 13G | ESSA PHARMA INC EPIX | RTW INVESTMENTS LP | 0 0% | -2,637,192 (Position Closed) | View |